| Unique ID issued by UMIN | UMIN000060427 |
|---|---|
| Receipt number | R000069024 |
| Scientific Title | A safety study on long-term consumption of a yogurt drink. |
| Date of disclosure of the study information | 2026/01/22 |
| Last modified on | 2026/01/21 17:49:25 |
A safety study on long-term consumption of a yogurt drink.
A safety study on long-term consumption of a yogurt drink.
A safety study on long-term consumption of a yogurt drink.
A safety study on long-term consumption of a yogurt drink.
| Japan |
N/A
| Not applicable | Adult |
Others
NO
To investigate the safety of 12 weeks consumption of a yogurt drink in a randomized, double-blind, placebo-controlled, parallel-group trial.
Safety
Number of subjects and events for adverse events (AEs) and for AEs related to the study products.
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
| Food |
Oral intake of the test food (yogurt drink, 112 g) once daily for 12 weeks.
Oral intake of placebo food (acidified milk, 112 g) daily for 12 weeks.
| 20 | years-old | <= |
| 65 | years-old | > |
Male and Female
(1) Healthy Japanese male and female aged 20 to 64 years at the time of consent.
(2) Subjects with a BMI >= 18.5 and < 30.0.
(3) Subjects who provide written informed consent.
(1) Subjects who have serious disease.
(2) Subjects who have taken any medication within 3 days prior to the screening test.
(3) Subjects with an average daily alcohol intake exceeding 40 g.
(4) Subjects unable to abstain from alcohol for 1 day prior to the examination.
(5) Subjects whose daily routines are irregular due to night work or shift work.
(6) Subjects who are expected to be unable to consume the study food for 6 or more days due to extended travel or similar circumstances.
(7) Subjects have participated in other research within 4 weeks prior to consent or plan to participate in other research after consent.
(8) Subjects who are pregnant, breastfeeding or intend to become pregnant during this study.
(9) Subjects who tend to develop diarrhea after consuming dairy products.
(10) Subject with food allergies.
(11) Subjects who donated blood component or 200 mL of whole blood within 1 month before this study.
(12) Males who donated 400 mL of whole blood within 3 months before this study.
(13) Females who donated 400 mL of whole blood within 4 months before this study.
(14) Males whose total blood draw volume, including the planned volume for this study, exceeds 1,200 mL within 12 months before this study.
(15) Females whose total blood draw volume, including the planned volume for this study, exceeds 800 mL within 12 months before this study.
(16) Subjects deemed unsuitable by the investigator.
40
| 1st name | Shukuko |
| Middle name | |
| Last name | Ebihara |
Chiyoda Paramedical Care Clinic
Director
103-0021
2F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo
03-6225-9505
cpcc-contact@cpcc.co.jp
| 1st name | Makoto |
| Middle name | |
| Last name | Ichinohe |
CPCC Company Limited
Director
103-0021
4F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo
03-6625-9001
cpcc-contact@cpcc.co.jp
CPCC Company Limited
Meiji Co., Ltd.
Profit organization
Institutional Review Board of Chiyoda Paramedical Care Clinic
2F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo 103-0021, Japan
03-6225-9005
IRB@cpcc.co.jp
NO
| 2026 | Year | 01 | Month | 22 | Day |
Unpublished
Preinitiation
| 2025 | Year | 10 | Month | 27 | Day |
| 2025 | Year | 10 | Month | 24 | Day |
| 2026 | Year | 01 | Month | 23 | Day |
| 2026 | Year | 04 | Month | 17 | Day |
| 2026 | Year | 01 | Month | 21 | Day |
| 2026 | Year | 01 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069024